SUSMED, Inc.
4263.T · JPX
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | ¥10 | ¥9 | ¥9 | ¥8 |
| - Cash | ¥4 | ¥5 | ¥5 | ¥5 |
| + Debt | ¥0 | ¥0 | ¥0 | ¥0 |
| Enterprise Value | ¥6 | ¥4 | ¥4 | ¥3 |
| Revenue | ¥0 | ¥0 | ¥1 | ¥0 |
| % Growth | 35.1% | -35.4% | 67.5% | – |
| Gross Profit | ¥0 | ¥0 | ¥1 | ¥0 |
| % Margin | 97.4% | 96.6% | 98.5% | 96.7% |
| EBITDA | -¥0 | -¥0 | -¥0 | -¥0 |
| % Margin | -62.5% | -104.8% | -8.3% | -72% |
| Net Income | -¥0 | -¥0 | -¥0 | -¥0 |
| % Margin | -64.5% | -104.3% | -9.6% | -73.7% |
| EPS Diluted | -17.77 | -21.41 | -3.09 | -15.9 |
| % Growth | 17% | -592.9% | 80.6% | – |
| Operating Cash Flow | -¥0 | -¥0 | ¥0 | -¥0 |
| Capital Expenditures | -¥0 | -¥0 | -¥0 | -¥0 |
| Free Cash Flow | -¥0 | -¥0 | ¥0 | -¥0 |